Geographic tongue

Summary

Geographic tongue (MONDO:0005771) is a disease and 3 clinical trials. A subtype of atrophic glossitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	geographic tongue
Mondo ID	MONDO:0005771
EFO	EFO:0007283
DOID	DOID:1455
ICD-10-CM	K14.1
ICD-11	1460387786
NCIT	C84588
SNOMED CT	59032001
UMLS	C0017677
MedGen	6619
Is cancer (heuristic)	no

Also known as: benign migratory glossitis · glossitis areata exfoliativa

Disease family

This is a subtype of atrophic glossitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › mouth disorder › tongue disorder › glossitis › atrophic glossitis › geographic tongue

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2
PHASE4	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT05190562	PHASE4	COMPLETED	Effectiveness of Zinc Supplementation in Management of Patients With Symptomatic Benign Migratory Glossitis
NCT01454492	Not specified	UNKNOWN	The Relationship Between Allergic Rhinitis and Geographic Tongue
NCT06988865	Not specified	COMPLETED	Benign Migratory Glossitis Associated With Antiangiogenic Drugs